SmPC - Pemetrexed Accord 25 mg/ml concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC - Pemetrexed Accord 25 mg/ml concentrate for solution for infusion)
Last updated on this site: 09 Apr 2025
To submit Type IAIN (C.I.3.a) variation to update section 4.5 of the SmPC and leaflet section 2 of the PL to implement the wording agreed by the CHMP following outcome of the PSUR procedure (EMEA/H/C/PSUSA/00002330/202402) for Pemetrexed.
View Summary of Product Characteristics (SmPC - Pemetrexed Accord 25 mg/ml concentrate for solution for infusion)
Last updated on this site: 09 Apr 2025
To submit Type IAIN (C.I.3.a) variation to update section 4.5 of the SmPC and leaflet section 2 of the PL to implement the wording agreed by the CHMP following outcome of the PSUR procedure (EMEA/H/C/PSUSA/00002330/202402) for Pemetrexed.
-
Changes: (Updated: 09 Apr 2025)
To submit Type IAIN (C.I.3.a) variation to update section 4.5 of the SmPC and leaflet section 2 of the PL to implement the wording agreed by the CHMP following outcome of the PSUR procedure (EMEA/H/C/PSUSA/00002330/202402) for Pemetrexed.
-
Changes: (Updated: 09 Nov 2022)
Initial upload